Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system - Wang, Shiyi; Wang, Xiaojian; Ding, Jing; Zhang, Xudong; Zhu, Hongmei; Fan, Yihong; Sun, Changbo (Frontiers in Pharmacology, 2025)